AMERICAN INTERNATIONAL GROUP, INC. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 94 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$12,455
+23.5%
99,879
+2.0%
0.00%
Q4 2022$10,083
-28.0%
97,890
+5.9%
0.00%
Q3 2022$14,000
-82.5%
92,451
+1.4%
0.00%
-100.0%
Q2 2022$80,000
-32.8%
91,146
-5.4%
0.00%0.0%
Q1 2022$119,000
-40.8%
96,333
-6.6%
0.00%0.0%
Q4 2021$201,000
-30.9%
103,114
-2.9%
0.00%
-50.0%
Q3 2021$291,000
-13.9%
106,198
-0.9%
0.00%
+100.0%
Q2 2021$338,000107,1990.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders